Home NDC 17856-2170 Acyclovir suspension
Product NDC 17856-2170
11-digit product format 178562170
Labeler code 17856
Product ID 17856-2170_5105272f-cff9-8898-e063-6394a90aabb5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form SUSPENSION
Route ORAL
Labeler Atlantic Biologicals Corp.
Application ANDA217393
Marketing category ANDA
Marketing start 2023-03-09
Substance ACYCLOVIR
Active strength 200 mg/5mL
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A217393-001 ACYCLOVIR ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A217393-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 053a50430f4f…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A217393-001 ACYCLOVIR 200MG/5ML SUSPENSION / ORAL AB 2023-03-09 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Acyclovir suspension
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 200 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination X4HES1O11F Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 307730 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 17856-2170-1 Acyclovir suspension 72 in 1 CASE SUSPENSION 72 1 17856-2170-1 Acyclovir suspension 5 mL in 1 CUP, UNIT-DOSE SUSPENSION 5 1 17856-2170-2 Acyclovir suspension 10 mL in 1 CUP, UNIT-DOSE SUSPENSION 10 1 17856-2170-2 Acyclovir suspension 72 in 1 CASE SUSPENSION 72 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 17856-2170-1 17856217001 72 CUP, UNIT-DOSE in 1 CASE (17856-2170-1) / 5 mL in 1 CUP, UNIT-DOSE 2026-05-04 No No Current 17856-2170-2 17856217002 72 CUP, UNIT-DOSE in 1 CASE (17856-2170-2) / 10 mL in 1 CUP, UNIT-DOSE 2026-05-04 No No Current